PMVP
Pmv PharmaceuticalsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PMVP Profile
Pmv Pharmaceuticals, Inc.
A precision oncology company that develops p53-targeted small molecule drugs for the treatment of cancer
One Research Way, Princeton, NJ 08540
--
Pmv Pharmaceuticals, Inc., was incorporated in Delaware in March 2013. The company is a precision oncology company dedicated to the discovery and development of small molecule, tumor-independent therapies for p53 mutations. P53 is a well-defined tumor suppressor protein known as the "guardian of the genome," while normal or wild-type p53 has the ability to eliminate cancer cells.
